Direct emissions
34,268
tCO2e
P
Pharmaron Beijing Co., Ltd.
Explore carbon emissions data for Pharmaron Beijing Co., Ltd.. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Pharmaron Beijing Co., Ltd., including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
739,331 tCO2e (Market Based)
Scope 1
tCO2e
34,268
Scope 2 (Market Based)
tCO2e
164,433
Scope 3 total
tCO2e
540,630
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Provenance
Emissions
Factors
551,622
kgCO2e / £M
Supplier specific emission factors (kgCO2e / £M)
Modelled
Reported
Scope 1 + 2
Direct + purchased energy
148,253
148,253
Upstream
+ upstream Scope 3
456,764
456,764
Total
+ all Scope 3
551,622
457,752
Which figure should I use?
Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.
Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.
When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Pharmaron Beijing Co., Ltd. reported 739,331 tCO₂e in 2024.
- Scope 3 accounted for 73% of emissions.
- Reported across 11 of 15 GHG Protocol Scope 3 categories.
- Scope 2 reported under the market based methodology.
According to available emissions disclosures, Pharmaron Beijing Co., Ltd. reported total yearly emissions of 739,331 tCO₂e in 2024. Scope 3 emissions accounted for 73% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.
The company achieved a Mycelium Score of 1.5, placing it well below average for its sector for sustainability performance, and received a transparency score of 37.0, pointing to very little public detail on their key emissions.
Total Emissions across all scopes
739,331 tCO2e (Market Based)
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
–
tCO2eMarket based
164,433
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
227,403
tCO2eCat 2
Capital goods
79,245
tCO2eCat 3
Fuel & energy related activities
57,103
tCO2eCat 4
Upstream transportation & distribution
9,204
tCO2eCat 5
Waste generated in operations
20,633
tCO2eCat 6
Business travel
1,114
tCO2eCat 7
Employee commuting
11,979
tCO2eCat 8
Upstream leased assets
6,812
tCO2eCat 9
Downstream transportation & distribution
855
tCO2eCat 10
Processing of sold products
1,997
tCO2eCat 11
Use of sold products
119,821
tCO2eCat 12
End-of-life treatment of sold products
8
tCO2eCat 13
Downstream leased assets
1,997
tCO2eCat 14
Franchises
1,997
tCO2eCat 15
Investments
462
tCO2e4 values were derived via Mycelium's normalisation process rather than reported by the company. Cells marked “–” were not disclosed.
Climate targets
Science Based Targets initiative
Near-term target
Targets set (1.5°C), target year 2033
Long-term target
Targets set, target year 2050
Net zero
Targets set, by 2050
Source: Science Based Targets initiative, Companies Taking Action.
Contact Info
Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Pharmaron Beijing Co., Ltd.'s score sits at the top of this page and in the score panel.
How the Transparency Score is calculated
The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.
For Pharmaron Beijing Co., Ltd., the single biggest gap is Use of sold products (Scope 3 Category 11). Mycelium estimates it accounts for around 16% of the company's total footprint, typically the largest source of emissions for a Services company, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
In total, roughly 16% of Pharmaron Beijing Co., Ltd.'s estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
Read the full scoring methodology
Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.
Download the white paper (PDF)
Pharmaron Beijing Co., Ltd. carbon emissions FAQs
What are Pharmaron Beijing Co., Ltd.'s carbon emissions?
In its 2024 reporting year, Pharmaron Beijing Co., Ltd. disclosed total emissions of 739,331 tCO2e across all scopes. Scope 3 accounted for the largest share, around 73% of the total.
Does Pharmaron Beijing Co., Ltd. report Scope 1, Scope 2 and Scope 3 emissions?
For 2024, Pharmaron Beijing Co., Ltd.'s available disclosure covers Scope 1 (34,268 tCO2e), Scope 2 (164,433 tCO2e), Scope 3 across 11 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Pharmaron Beijing Co., Ltd.'s emissions reporting?
Pharmaron Beijing Co., Ltd. has a Mycelium transparency score of 37 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.
Is Pharmaron Beijing Co., Ltd. sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Pharmaron Beijing Co., Ltd. has a Mycelium Score of 1.5 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.
Is Pharmaron Beijing Co., Ltd. environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Pharmaron Beijing Co., Ltd. disclosed 739,331 tCO2e for 2024, and its Mycelium Score of 1.5 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.
